Initial experience with the subcutaneous implantable cardioverter-defibrillator in a single Japanese center

• Published in: Journal of arrhythmia 2017-08, Vol.33 (4), p.338-341
• Main Authors: Nishii, Nobuhiro, MD, Tachibana, Motomi, MD, Morimoto, Yoshimasa, MD, Kawada, Satoshi, MD, Miyoshi, Akihito, MD, Sugiyama, Hiroyasu, MD, Nakagawa, Koji, MD, Watanabe, Atsuyuki, MD, Nakamura, Kazufumi, MD, Morita, Hiroshi, MD, Ito, Hiroshi, MD
• Format: Article
• Language: English
• Subjects: Body mass index; Cardiac arrhythmia; Cardiomyopathy; Cardiovascular; Cardiovascular disease; Conflicts of interest; Electrocardiography; Patients; Rapid Communication; Subcutaneous implantable cardioverter-defibrillator; Sudden cardiac death; T-wave oversensing
• ISSN: 1880-4276; 1883-2148
• DOI: 10.1016/j.joa.2017.02.004

Abstract Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) is recognized as a viable alternative to the transvenous ICD. The safety and efficacy of this device has been demonstrated in Western countries, but studies with S-ICD implantation in Japanese patients have not been reported. Methods and results Twelve patients received an S-ICD implant in our institute between February and September 2016. All S-ICDs were successfully implanted without complications. One appropriate and one inappropriate therapy was identified. Conclusions S-ICD implantation appears to provide a viable alternative to transvenous ICD implantation for some Japanese patients. However, we should perform careful follow-up of patients to eliminate inappropriate therapy.